|1.||Sunada, Yoshihide: 3 articles (11/2011 - 11/2006)|
|2.||Amato, Anthony A: 2 articles (01/2009 - 05/2008)|
|3.||Walsh, Ronan: 1 article (01/2009)|
|4.||Krivickas, Lisa S: 1 article (01/2009)|
|5.||Eagle, Michelle: 1 article (05/2008)|
|6.||Bushby, Katharine: 1 article (05/2008)|
|7.||Wagner, Kathryn R: 1 article (05/2008)|
|8.||Fleckenstein, James L: 1 article (05/2008)|
|9.||Csimma, Cristina: 1 article (05/2008)|
|10.||Pestronk, Alan: 1 article (05/2008)|
|1.||Muscular Dystrophies (Muscular Dystrophy)
01/01/2009 - "Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029."
05/01/2008 - "A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy."
11/01/2006 - "A human anti-myostatin monoclonal antibody, MYO-029 is under clinical trials in patients with muscular dystrophy in the USA and Europe. "
11/01/2011 - "Although a clinical trial of anti-myostatin antibody MYO-029 failed to achieve a significant outcome in patients with muscular dystrophies, various distinct approaches have been taken to establish anti-myostatin therapy, including myostatin decoy receptor ACE-031, small-molecule inhibitors against the myostatin receptor, and myostatin short intertering RNA with collagen-derived carrier particles. "
05/01/2008 - "We conducted a safety trial of a neutralizing antibody to myostatin, MYO-029, in adult muscular dystrophies (Becker muscular dystrophy, facioscapulohumeral dystrophy, and limb-girdle muscular dystrophy). "
|2.||Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
|3.||Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
|5.||Small Interfering RNA (siRNA)
|6.||RNA (Ribonucleic Acid)